Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
Gerd R Burmester(Charité - Universitätsmedizin Berlin), Ricardo Blanco(Marqués de Valdecilla University Hospital), Christina Charles‐Schoeman(University of California, Los Angeles), J. Wollenhaupt(Schön Klinik Hamburg Eilbek), Cristiano A. F. Zerbini(Hospital Heliópolis), Birgitta Benda(Pfizer (United States)), David Gruben(Pfizer (United States)), Gene V. Wallenstein(Pfizer (United States)), Sriram Krishnaswami(Pfizer (United States)), Samuel H. Zwillich(Pfizer (United States)), Tamás Koncz(Pfizer (United States)), Koshika Soma(Pfizer (United States)), John Bradley(Pfizer (United States)), Charles A. Mebus(Pfizer (United States))
Cited by 718
Abstract
Related Papers
No related papers found
Powered by citation graph analysis